Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-6 induces hepcidin expression through STAT3.

Diedra M Wrighting1, Nancy C Andrews

  • 1graduate program in Biological and Biomedical Sciences, Harvard University, Boston, MA, USA.

Blood
|July 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Funding FAIRly: A New Model for Biomedical Research.

Journal of the American Society of Nephrology : JASN·2026
Same author

David Baltimore: Scientist, leader, and mentor.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Isn't it ironic? Functional iron deficiency at the core of Parkinson's disease pathobiology.

The Journal of clinical investigation·2026
Same author

The Urgent Need for More Federal Funding for Pediatric Firearm Injury Prevention Research.

Pediatrics·2025
Same author

International Precision Child Health Partnership (IPCHiP): an initiative to accelerate discovery and improve outcomes in rare pediatric disease.

NPJ genomic medicine·2025
Same author

Hospital-wide access to genomic data advanced pediatric rare disease research and clinical outcomes.

NPJ genomic medicine·2024
Same journal

Decentralized Clinical Trials in Hematology: the Promise and the Peril.

Blood·2026
Same journal

How I Treat Chemotherapy-Induced Thrombocytopenia with Thrombopoietin Receptor Agonists.

Blood·2026
Same journal

The Chaos of Choice in Large B-cell Lymphoma: A Call to Harmonize First-line Trial Design.

Blood·2026
Same journal

Precision Transfusion Medicine in the Omics Era.

Blood·2026
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
See all related articles

This study reveals how interleukin-6 (IL-6) controls hepcidin production via signal transducer and activator of transcription 3 (STAT3). This finding clarifies mechanisms of iron regulation influenced by inflammation and other factors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Physiology

Background:

  • Iron homeostasis is crucial for health, regulated by hepcidin.
  • Dysregulated hepcidin causes iron overload or deficiency.
  • Mechanisms linking inflammation and hepcidin are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanism by which interleukin-6 (IL-6) regulates hepcidin expression.
  • To identify the role of signal transducer and activator of transcription 3 (STAT3) in IL-6-mediated hepcidin regulation.

Main Methods:

  • Investigated the direct regulation of hepcidin by IL-6.
  • Analyzed the role of STAT3 in the IL-6 response pathway.
  • Examined STAT3 binding to the hepcidin promoter.

Related Experiment Videos

Main Results:

  • Demonstrated that IL-6 directly induces hepcidin expression.
  • Showed that STAT3 is essential for IL-6-induced hepcidin promoter activity.
  • Confirmed STAT3 binding to the hepcidin promoter following IL-6 stimulation.

Conclusions:

  • IL-6 directly regulates hepcidin through STAT3 activation and promoter binding.
  • This provides a mechanistic link between inflammation and iron homeostasis.
  • Identified STAT3 as a key mediator for hepcidin regulation by inflammation or alternative pathways.